Clinical Trial Update: Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating rilzabrutinib in adults and adolescents with persistent or chronic immune thrombocytopenia has results posted and the trial is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Rilzabrutinib (rilzabrutinib)

Snippet

Sponsor: Principia Biopharma, a Sanofi Company | Conditions: Immune Thrombocytopenia | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-02-23